KROS · Keros Therapeutics, Inc. · Proposed Sales
$10.08
+0.54 (+5.66%)
At close · Nov 12
Return incl. dividend (before tax)
Market Cap
$197.81M
Shares
19.62M
Volume · Nov 12
630.16K
Avg daily vol (3M)
187.94K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-11-12 | Prener Anne | Director | 574 | 2026-11-12 | UBS Financial Services Inc. |
| 2026-08-18 | Newton Charles W. | Director | 551 | 2026-08-18 | UBS Financial Services, Inc. |
| 2026-06-11 | Newton Charles W. | Director | 550 | 2026-06-11 | UBS Financial Services, Inc. |
| 2026-06-04 | Knowles Julius | Director | 2,625 | 2026-06-04 | UBS Financial Services, Inc. |
| 2026-06-04 | Farzan Nima | Director | 2,625 | 2026-06-04 | UBS Financial Services, Inc. |
| 2026-06-04 | Seth Alpna | Director | 2,625 | 2026-06-04 | UBS Financial Services, Inc. |
| 2026-03-31 | OrbiMed Genesis Master Fund, LP | Shareholder, Director | 45,057 | 2026-03-31 | Themis Trading LLC |
| 2025-09-12 | Rovaldi Christopher | Affiliate | 85,306 | 2025-09-12 | UBS Financial Services Inc. |
| 2024-08-13 | OrbiMed Genesis Master Fund, LP | Shareholder, Director | 29,400 | 2024-08-13 | Morgan Stanley Smith Barney |
| 2024-08-13 | OrbiMed Private Investments VII, LP | Shareholder, Director | 220,600 | 2024-08-13 | Morgan Stanley Smith Barney |
| 2024-01-04 | Regnante Keith | Officer | 40,000 | 2024-01-04 | UBS Financial Services, Inc. |
| 2023-12-11 | The Biotech Growth Trust PLC | Shareholder | 246,000 | 2023-12-11 | Themis Trading LLC |
| 2023-06-12 | The Biotech Growth Trust PLC | Shareholder | 170,000 | 2023-06-12 | Evercore ISI |
| 2023-06-09 | Regnante Keith | Officer | 20,000 | 2023-06-09 | UBS Financial Services, Inc. |
| 2023-06-08 | Regnante Keith | Officer | 20,000 | 2023-06-08 | UBS Financial Services, Inc. |
Showing 1–15 of 15 filings
Key facts
CIK
1664710
CUSIP
492327101
13F (30d)
85 filings
70 filers
Visit website
Investor relations